Newsletter | September 8, 2021

09.08.21 -- Patient Engagement And Data Collection For Decentralized Trials

Implementing Solutions To Virtualize And Decentralize Clinical Trials

Traditional clinical trials are multisite human studies that integrate numerous in-person study visits and endpoints. However, as clinical studies become more complex, it is more important than ever to develop new trial models that can accommodate novel endpoints and provide greater flexibility to study participants.

Real-World Evidence In Clinical Trials

Recent technological innovations have expanded the potential for the collection of real-world evidence (RWE) in clinical trials. Read how, through patients’ personal devices, fixed in-home sensors, or third-party wearable devices (e.g., Fitbit) and biological sensors, researchers can now collect valid data representing a wide array of constructs.

Better Experience, Better Results: 5 Must-Haves For Any Decentralized Trial

By reshaping the patient experience, clinical trials can better recruit and retain patients across ages, races, ethnicities, socioeconomic status, and levels of educational attainment. In this article, the five must-haves for any decentralized trial are discussed.

Advancing Decentralized Trials Using An mHealth Platform

While COVID-19 has ushered in some much-needed innovations in terms of technology solutions to power decentralized trials, not all solutions are created equal. When evaluating mHealth technology, for example, the integrity of data collection and data privacy are paramount. This webinar discusses the key considerations when making an investment in an mHealth platform.

Patients Or Players? Gamification As A Patient-Centric Retention Strategy For Clinical Trials

The National Academy of Science found patient dropout rates to be as high as 30 percent in clinical trials. In this article, find out how missing outcome data caused by patient dropout and poor compliance not only jeopardizes the scientific validity of a study but also comes at a significant financial cost to sponsors.